⌘K

Login Start Free

Home/Filings/4/0001104659-21-000927

4//SEC Filing

Mann Brenda 4

Accession 0001104659-21-000927

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:15 PM ET

Size

4.7 KB

Accession

0001104659-21-000927

Insider Transaction Report

Form 4

Period: 2021-01-04

EYEGATE PHARMACEUTICALS INCEYEG

VP of Research & Development

Transactions

Tax Payment
Common Stock
2021-01-04$4.85/sh−115$558→ 17,256 total

Footnotes (1)

[F1]Sale of shares to cover taxes due on restricted stock that vested on 01/01/2021.

Documents

1 file

4
tm211689-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001668858

Filing Metadata

Form type: 4
Filed: Jan 4, 7:00 PM ET
Accepted: Jan 5, 4:15 PM ET
Size: 4.7 KB

View on SEC.gov